ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2512

Changes in Bone Marrow Lesion Volume Relate to Changes in Knee Pain. Data From the Osteoarthritis Initiative

Jeffrey B. Driban1, Lori Lyn Price2, Grace H. Lo3, Jincheng Pang4, Eric Miller4, Charles Eaton5, John A. Lynch6 and Timothy E. McAlindon7, 1Rheumatology, Tufts Medical Center, Boston, MA, 2Biostatistics Research Center, Institute for Clinical Research and Health Policy Studies, Tufts Medical Center, Boston, MA, 3Michael E. DeBakey Veterans Affairs Medical Center, Houston, TX, 4Department of Electrical and Computer Engineering, Tufts University, Medford, MA, 5Center for Primary Care and Prevention, Memorial Hospital of Rhode Island, Providence, RI, 6Department of Epidemiology and Biostatistics, University of California at San Francisco, San Francisco, CA, 7Division of Rheumatology, Tufts Medical Center, Boston, MA

Meeting: 2012 ACR/ARHP Annual Meeting

Keywords: Knee, Magnetic resonance imaging (MRI), osteoarthritis and pain

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Title: ACR/ARHP Combined Epidemiology Abstract Session

Session Type: Combined Abstract Sessions

Background/Purpose: Changes in bone marrow lesions (BMLs), common magnetic resonance (MR) imaging findings in osteoarthritis (OA), are predictive of OA progression. However, it is unclear if quantitative measurements of BML volume change are related to knee pain. Therefore, the purpose of this study was to determine whether quantitative measures of BML volume change are positively associated with knee pain change.

Methods: The sample comprised 404 participants in the Osteoarthritis Initiative (OAI) progression cohort who had sagittal intermediate-weighted, turbo spin echo, fat-suppressed MR images at the 24- and 48- month OAI visits. The right knee was assessed unless contraindicated. BML volume was determined on the sagittal fat-suppressed MR images by one rater using a semi-automated segmentation method (ICC [3,1 model] = 0.95). BML volumes were calculated for each knee region and then summed to form a total knee BML volume (cm3). Knee pain was defined based on WOMAC pain score at the 24- and 48-month OAI visits. Multiple linear regressions were used to evaluate the association between the WOMAC pain, as an outcome, and BML volume while controlling for sex, weight, height, and age. To further explore these associations we assessed the associations stratified among tertiles based on baseline BML volume. Based on diagnostic tests (e.g., DFFITs, Cook’s D) for the linear regression models among tertiles we opted to perform robust regression models. WOMAC scores and participant characteristics are available at http://oai.epi-ucsf.org.

Results: The cohort included 199 (49%) females and were 64.9 ± 9.2 years old, 85.3 ± 16.2 kg, and 1.7 ± 0.1 m. The average baseline total knee BML volume was 2.6 ± 2.7 cm3 (range =0.1 to 10.2 cm3). Total knee BML volume change was -0.2 ± 2.1 cm3 (range =-12.7 to 10.2 cm3; see Figure). Larger BML volumes are associated with greater knee pain and larger BML volume changes are associated with worsening knee pain (see Table). Stratified analyses by baseline BML volume (tertiles) indicated that only in the first tertile (no BMLs or BMLs < 1.0 cm3) was BML volume change and WOMAC pain change significantly related (estimate = 0.65, standard error =0.25, p = 0.009).

Conclusion: Change in BML volume is associated with change in knee pain severity. This association may primarily be driven by knees that are progressing from no or small BML volumes to larger BML volumes.

 

Table. Cross-sectional and Longitudinal Association between BML Volume and WOMAC Pain

 

Outcome Variable Stratified by Baseline BML Volume Tertile

Descriptives

Mean ± SD

Models* with Baseline BML Volume

B (p-value)

Models* with BML Volume Change

B (p-value)

Full Cohort (n = 404)

 

 

 

     WOMAC pain (baseline)

3.3 ± 3.4

0.16 (0.01)

n/a

     WOMAC pain (change)

0.0 ± 3.0

-0.01 (0.87)

0.21 (0.004)

* All models adjusted for sex, weight, height, and age. SD = standard deviation, BML = bone marrow lesion, B = parameter estimate, n/a = not assessed.

Figure. Scatter plot of WOMAC Pain Change by BML Volume Change Stratified by Tertiles (colors). Tertiles, based on baseline BML volume, had average baseline total knee BML volumes of 0.6 ± 0.2 cm3, 1.6 ± 0.5 cm3, and 5.5 ± 2.9 cm3; respectively.


Disclosure:

J. B. Driban,
None;

L. L. Price,
None;

G. H. Lo,
None;

J. Pang,
None;

E. Miller,
None;

C. Eaton,
None;

J. A. Lynch,
None;

T. E. McAlindon,
None.

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2012 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/changes-in-bone-marrow-lesion-volume-relate-to-changes-in-knee-pain-data-from-the-osteoarthritis-initiative/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology